These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28057037)

  • 1. Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis.
    Masarwa R; Paret G; Perlman A; Reif S; Raccah BH; Matok I
    Crit Care; 2017 Jan; 21(1):1. PubMed ID: 28057037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin in catecholamine-refractory shock in children.
    Meyer S; Gortner L; McGuire W; Baghai A; Gottschling S
    Anaesthesia; 2008 Mar; 63(3):228-34. PubMed ID: 18081903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and its analogues for the treatment of refractory hypotension in neonates.
    Shivanna B; Rios D; Rossano J; Fernandes CJ; Pammi M
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009171. PubMed ID: 23543571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
    Rehberg S; Ertmer C; Köhler G; Spiegel HU; Morelli A; Lange M; Moll K; Schlack K; Van Aken H; Su F; Vincent JL; Westphal M
    Intensive Care Med; 2009 Jul; 35(7):1286-96. PubMed ID: 19360396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of vasopressin in pediatric patients.
    Agrawal A; Singh VK; Varma A; Sharma R
    Indian Pediatr; 2012 Apr; 49(4):297-305. PubMed ID: 22565074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children.
    Yildizdas D; Yapicioglu H; Celik U; Sertdemir Y; Alhan E
    Intensive Care Med; 2008 Mar; 34(3):511-7. PubMed ID: 18092150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study.
    Rodríguez-Núñez A; López-Herce J; Gil-Antón J; Hernández A; Rey C;
    Crit Care; 2006 Feb; 10(1):R20. PubMed ID: 16469127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis.
    Huang L; Zhang S; Chang W; Xia F; Liu S; Yang Y; Qiu H
    BMC Anesthesiol; 2020 Mar; 20(1):58. PubMed ID: 32138657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.
    Meyer S; McGuire W; Gottschling S; Mohammed Shamdeen G; Gortner L
    Wien Med Wochenschr; 2011 Apr; 161(7-8):192-203. PubMed ID: 21253815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin analogues in the treatment of shock states: potential pitfalls.
    Ertmer C; Rehberg S; Westphal M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):393-406. PubMed ID: 18683484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
    Lange M; Ertmer C; Westphal M
    Intensive Care Med; 2008 May; 34(5):821-32. PubMed ID: 18066524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin in hemorrhagic shock: a systematic review and meta-analysis of randomized animal trials.
    Cossu AP; Mura P; De Giudici LM; Puddu D; Pasin L; Evangelista M; Xanthos T; Musu M; Finco G
    Biomed Res Int; 2014; 2014():421291. PubMed ID: 25254206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin in sepsis and septic shock.
    Kampmeier TG; Rehberg S; Westphal M; Lange M
    Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of terlipressin on patients with sepsis via improving tissue blood flow.
    Xiao X; Zhang J; Wang Y; Zhou J; Zhu Y; Jiang D; Liu L; Li T
    J Surg Res; 2016 Jan; 200(1):274-82. PubMed ID: 26253455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Terlipressin in Pediatric Distributive Shock: A Retrospective Analysis in 20 Children.
    Michel J; Hofbeck M; Spiller G; Renk H; Kumpf M; Neunhoeffer F
    Paediatr Drugs; 2017 Feb; 19(1):35-41. PubMed ID: 27766555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of terlipressin in pediatric cardiac arrest.
    Yilidzdaş D; Horoz OO; Erdem S
    Pediatr Emerg Care; 2011 Sep; 27(9):865-8. PubMed ID: 21926888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.